搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Fusobacterium nucleatum subsp. nucleatum 50S ribosomal protein L33 (rpmG) CSB-YP840390FDQ
CSB-EP840390FDQ
CSB-BP840390FDQ
CSB-MP840390FDQ
CSB-EP840390FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusobacterium nucleatum subsp. nucleatum 50S ribosomal protein L7/L12 (rplL) CSB-YP840391FDQ
CSB-EP840391FDQ
CSB-BP840391FDQ
CSB-MP840391FDQ
CSB-EP840391FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusobacterium nucleatum subsp. nucleatum ATP-dependent Clp protease ATP-binding subunit ClpX (clpX) CSB-YP840392FDQ
CSB-EP840392FDQ
CSB-BP840392FDQ
CSB-MP840392FDQ
CSB-EP840392FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusobacterium nucleatum subsp. nucleatum Bifunctional protein GlmU (glmU) CSB-YP840393FDQ
CSB-EP840393FDQ
CSB-BP840393FDQ
CSB-MP840393FDQ
CSB-EP840393FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusobacterium nucleatum subsp. nucleatum Dephospho-CoA kinase (coaE) CSB-YP840394FDQ
CSB-EP840394FDQ
CSB-BP840394FDQ
CSB-MP840394FDQ
CSB-EP840394FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusobacterium nucleatum subsp. nucleatum 3-keto-5-aminohexanoate cleavage enzyme (kce) CSB-YP840395FDQ
CSB-EP840395FDQ
CSB-BP840395FDQ
CSB-MP840395FDQ
CSB-EP840395FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusobacterium nucleatum subsp. nucleatum Enolase (eno) CSB-YP840396FDQ
CSB-EP840396FDQ
CSB-BP840396FDQ
CSB-MP840396FDQ
CSB-EP840396FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusobacterium nucleatum subsp. nucleatum V-type ATP synthase subunit D (atpD) CSB-YP840397FDQ
CSB-EP840397FDQ
CSB-BP840397FDQ
CSB-MP840397FDQ
CSB-EP840397FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusobacterium nucleatum subsp. nucleatum Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP840398FDQ
CSB-EP840398FDQ
CSB-BP840398FDQ
CSB-MP840398FDQ
CSB-EP840398FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusobacterium nucleatum subsp. nucleatum 30S ribosomal protein S10 (rpsJ) CSB-YP840399FDQ
CSB-EP840399FDQ
CSB-BP840399FDQ
CSB-MP840399FDQ
CSB-EP840399FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusobacterium nucleatum subsp. nucleatum 30S ribosomal protein S19 (rpsS) CSB-YP840400FDQ
CSB-EP840400FDQ
CSB-BP840400FDQ
CSB-MP840400FDQ
CSB-EP840400FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusobacterium nucleatum subsp. nucleatum 50S ribosomal protein L6 (rplF) CSB-YP840401FDQ
CSB-EP840401FDQ
CSB-BP840401FDQ
CSB-MP840401FDQ
CSB-EP840401FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusobacterium nucleatum subsp. nucleatum Cytidylate kinase (cmk) CSB-YP840402FDQ
CSB-EP840402FDQ
CSB-BP840402FDQ
CSB-MP840402FDQ
CSB-EP840402FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusobacterium nucleatum subsp. nucleatum 30S ribosomal protein S7 (rpsG) CSB-YP840403FDQ
CSB-EP840403FDQ
CSB-BP840403FDQ
CSB-MP840403FDQ
CSB-EP840403FDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Type III secretion ATP synthase HrcN (hrcN) CSB-YP840404FGN
CSB-EP840404FGN
CSB-BP840404FGN
CSB-MP840404FGN
CSB-EP840404FGN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Antilisterial bacteriocin subtilosin biosynthesis protein AlbG (albG), partial CSB-YP840405BRI1
CSB-EP840405BRI1
CSB-BP840405BRI1
CSB-MP840405BRI1
CSB-EP840405BRI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis subsp. spizizenii Putative CDP-glycerol:glycerophosphate glycerophosphotransferase tarB (tarB), partial CSB-YP840406BRM
CSB-EP840406BRM
CSB-BP840406BRM
CSB-MP840406BRM
CSB-EP840406BRM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lipase chaperone (lifO), partial CSB-YP840407PUO
CSB-EP840407PUO
CSB-BP840407PUO
CSB-MP840407PUO
CSB-EP840407PUO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenorhabdus nematophila 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) CSB-YP840408XBH
CSB-EP840408XBH
CSB-BP840408XBH
CSB-MP840408XBH
CSB-EP840408XBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Major surface protein mspTL (mspTL), partial CSB-YP840409TEAV
CSB-EP840409TEAV
CSB-BP840409TEAV
CSB-MP840409TEAV
CSB-EP840409TEAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>